{"id":"W4230099636","doi":"10.1200/jco.2019.37.7_suppl.432","title":"First-line PD1/PD-L1 inhibitors for platinum-ineligible advanced urothelial carcinoma (UC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Durvalumab; Nivolumab; Internal medicine; Cisplatin; Gastroenterology; Urology; Oncology; Surgery; Cancer; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009930667,0.0001699474,0.0003923581,0.0003746045,0.0002994884,0.0005205986,0.0003860684,0.0002976314,0.001624669],"category_scores_gemma":[0.002364544,0.0001205989,0.0004113088,0.0006839308,0.0002398912,0.0003703891,0.0003893818,0.0005554968,0.0004730643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005118877,"about_ca_system_score_gemma":0.0007869265,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000434025,"about_ca_topic_score_gemma":0.0008375978,"domain_scores_codex":[0.9993687,0.0001590026,0.0001274764,0.000127633,0.0001451856,0.00007190743],"domain_scores_gemma":[0.9970529,0.0005097437,0.001804157,0.0001356833,0.000147631,0.0003498631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001476115,0.0002121229,0.9538506,0.0005790361,0.0001262643,0.0009473698,0.0001154378,0.0003417575,0.001904349,0.00007866209,0.001405732,0.03896245],"study_design_scores_gemma":[0.0002283759,0.003364593,0.9677429,0.0001817001,0.0002661517,0.01121211,0.0001534616,0.0007472785,0.004046298,0.00008376457,0.01196183,0.00001155345],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840276,0.009757126,0.0008562764,0.0003609863,0.00003334525,0.000165823,0.002495877,0.00003837594,0.002264664],"genre_scores_gemma":[0.9945611,0.002093487,0.0006572456,0.0002902299,0.00006594404,0.00006658725,0.001794905,0.000007483197,0.0004629441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001624669,"threshold_uncertainty_score":0.00543505,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0845193435001139,"score_gpt":0.4387206548824291,"score_spread":0.3542013113823152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}